A 22-year-old dialysis patient presents to the ER with chest pain and palpitations. Laboratory tests reveal a Potassium (K+) level of 7.0 mEq/L. Which electrolyte imbalance is the patient suffering from?

A. Pantoprazole belongs to a class of medications called proton pump inhibitors (PPIs), which work by reducing the production of gastric acid in the stomach. This helps in treating conditions such as gastroesophageal reflux disease (GERD) and heartburn effectively.

B. Pantoprazole is not known to cause hyperkalemia. Hyperkalemia is a condition characterized by high levels of potassium in the blood, and it is typically associated with certain medications (e.g., potassium- sparing diuretics) or medical conditions affecting kidney function. Pantoprazole's primary side effects relate to its effects on gastric acid production and absorption of certain nutrients.

C. While pantoprazole is usually taken once daily, the timing of administration is typically in the morning, before a meal. This helps to maximize its effectiveness in reducing gastric acid secretion when the stomach acid production is at its highest.

D. Pantoprazole should be taken on an empty stomach, at least 30 minutes before a meal. This timing allows the medication to be absorbed properly and work effectively to reduce gastric acid production.

D. Holding the skin taut helps stabilize the area and ensures that the needle penetrates the skin smoothly and at the correct angle. This also helps prevent the needle from going too deep or slipping out of the site during injection.

A. The syringe should be held at a 5 to 15-degree angle to the client's skin, not 20 degrees.

B. For a tuberculin skin test (PPD test), typically 0.1 mL (one-tenth of a milliliter) of PPD is injected intradermally. This is a very small amount compared to 0.5 mL.

C. The length of the needle for an intradermal injection is typically shorter than 1 inch, usually around 3/8 to 5/8 inches (10-16 mm). Using a longer needle may increase the risk of inserting the needle too deeply, potentially leading to subcutaneous rather than intradermal injection.